The risk of reverse zoonotic transmission to pet animals during the current global monkeypox outbreak, United Kingdom, June to mid-September 2022

Shepherd, Wendi; Beard, Philippa M.; Brookes, Sharon M; Frost, Andrew; Roberts, Helen; Russell, Katherine; Wyllie, Steve

doi:10.2807/1560-7917.es.2022.27.39.2200758

Cited by 15 publications

(11 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, in June 2022, the evidence of the first human-to-dog transmission of Mpox in France was published in the Lancet on August 10 [22] . Additional cases have been notified in Brazil [23] .…”

Section: Risk Assessment Of Mpoxmentioning

confidence: 99%

Mpox: Risks and approaches to prevention

Amer¹,

Khalifa²,

Elahmady³

et al. 2023

Journal of Infection and Public Health

View full text Add to dashboard Cite

Section: Risk Assessment Of Mpoxmentioning

confidence: 99%

Mpox: Risks and approaches to prevention

Amer¹,

Khalifa²,

Elahmady³

et al. 2023

Journal of Infection and Public Health

View full text Add to dashboard Cite

“…In the past, Clade I (formerly known as the Congo Basin clade) was responsible for several serious outbreaks of disease throughout history [ 17 , 18 ]. In contrast, Clade II (formerly the West African clade) is associated with the current global mpox outbreak in 2022, which is dominated by Europe and North America [ 19 ]. The findings of several serological studies suggest that MPXV is primarily maintained by mammalian species in Africa, which may explain why MPXV was only prevalent in Africa in the past [ 12 , 20 , 21 , 22 ].…”

Section: General Characteristics Of the Mpox Virusmentioning

confidence: 99%

Mpox (Monkeypox) and the Eye: Ocular Manifestation, Diagnosis, Treatment and Vaccination

Zong

Kamoi

Zhang

et al. 2023

Viruses

View full text Add to dashboard Cite

At present, the world is at the tipping point of the outbreak of mpox. The World Health Organization has declared the current mpox outbreak a ‘public health emergency of international concern.’ Mpox has been shown to be associated with several ocular manifestations. Given the current state of the mpox outbreak, healthcare providers, particularly ophthalmologists, need to be aware of these ophthalmic symptoms and how to manage them. In this review, we highlight current knowledge on the ocular symptoms of mpox virus (MPXV) infections and how to detect them. In addition, we summarize the treatment strategies for these ocular manifestations of MPXV infections and outline the relationship between vaccination and the ocular symptoms of mpox.

show abstract

“…44 The reported cases of mpox in dogs suggest the potential for reverse zoonosis transmission of the mpox virus (Clade IIb). 45 However, combined surveillance and observations in the UK found no evidence of the mpox virus in pets, and the risk of mpox virus reverse zoonosis was assessed to be low. 45 Moreover, because the first reported human-to-dog transmission of mpox virus was detected by PCR in a cutaneous swab, but the dog was negative by serology, 43 it is unclear whether the dog was infected or the PCR just detected surface-contaminated virus.…”

Section: Mpox Virusmentioning

confidence: 99%

Continuous surveillance and viral discovery in animals and humans are a core component of a one-health approach to address recent viral reverse zoonoses

Kibenge

2023

javma

View full text Add to dashboard Cite

Contemporary human and animal viruses have a broad or narrow host range—those with a broad host range are potentially transmitted from animals to humans (ie, zoonosis) or humans to animals (ie, reverse zoonosis). This Currents in One Health article reviews the recent reverse zoonoses involving Coronaviridae, Poxviridae, arboviruses, and, for nonhuman primate species, the human respiratory viruses. The prevention and control of reverse zoonoses are also reviewed. Coronaviruses continue to emerge as new zoonotic agents, including a canine coronavirus, CCoV-HuPn-2018, circulating in people at low levels, and a pangolin coronavirus, MjHKU4r-CoV-1, circulating in Malayan pangolins. Moreover, the risk for SARS-CoV-2 variants to mutate in animal reservoirs and reinfect humans is ongoing. In the case of mpox, the risk of reverse zoonosis is low and there are vaccines for use in humans at risk. The situation with arboviruses is as varied as the number of human arboviruses, and only yellow fever virus and dengue virus have licensed vaccines in the Americas. As for reverse zoonoses in endangered species, solutions require changing human behavior and policies at all levels impacting wildlife. Overall, continuous surveillance and viral discovery in humans and animals remain core components of a one-health approach to reduce and, where possible, eliminate zoonotic and reverse zoonotic diseases. Viral zoonosis and viral reverse zoonosis focusing on recent influenza A virus disease events in humans and other species are the subjects of the companion Currents in One Health by Kibenge, AJVR, June 2023.

show abstract

The risk of reverse zoonotic transmission to pet animals during the current global monkeypox outbreak, United Kingdom, June to mid-September 2022

Cited by 15 publications

References 12 publications

Mpox: Risks and approaches to prevention

Mpox: Risks and approaches to prevention

Mpox (Monkeypox) and the Eye: Ocular Manifestation, Diagnosis, Treatment and Vaccination

Continuous surveillance and viral discovery in animals and humans are a core component of a one-health approach to address recent viral reverse zoonoses

Contact Info

Product

Resources

About